ECC-5004

• Description :

  ECC-5004 (Compound 1) is a GLP-1 receptor agonist with an EC50 of 0-20 nM. ECC-5004 exhibits strong inhibitory effects on OATP1B1, with an IC50 [1].

• UNSPSC :

  12352005

• Target :

  GLP Receptor

• Related Pathways :

  GPCR/G Protein

• Field of Research :

  Metabolic Disease

• Smiles :

  CC1=CC(N2N=C3CCN([C@H](C3=C2N4C=CN(C4=O)C5=C(C6=C(N(N=C6)C)C=C5)F)C)C(C7=C(N8C=CC([C@H]9CCOC(C)(C9)C)=CC8=C7)[C@]%10(C[C@@H]%10C)C%11=NOC(N%11)=O)=O)=CC(C)=C1F

• Molecular Formula :

  C48H48F2N10O5

• Molecular Weight :

  882.96

• References & Citations :

  [1]Zaifang REN, et al. Tetrahydropyrazolo-pyrazinyl-dihydroimidazolone or tetrahydropyrazolo-pyridinyl-dihydroimidazolone compounds and methods of using same. WO2022017338A1.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported